Welcome to our dedicated page for Intel SEC filings (Ticker: INTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Intel Corporation’s (Nasdaq: INTC) SEC filings, offering a detailed view of how the company reports its operations, financial condition and material events. Intel uses filings such as Forms 10-K and 10-Q to present consolidated financial statements, segment information for Intel Products and Intel Foundry, and discussions of risks and opportunities in the semiconductor and related device manufacturing industry.
For investors focused on quarterly and annual performance, Intel’s periodic reports describe revenue, margins, operating expenses and segment trends for areas such as the Client Computing Group and Data Center and AI. These filings also explain non-GAAP measures that Intel uses internally, with reconciliations to GAAP metrics. AI-powered tools on this page can help summarize lengthy documents, highlight key sections and clarify technical terminology, saving time for readers who want to understand the main points of each filing.
Intel’s Current Reports on Form 8-K are especially relevant for tracking material events. Recent 8-K filings have covered topics such as the sale of a majority interest in the Altera business, securities purchase agreements with NVIDIA and SoftBank, a Warrant and Common Stock Agreement with the U.S. Department of Commerce under the CHIPS Act framework, and changes to the Direct Funding Agreement that governs certain government disbursements. Other 8-Ks have disclosed director appointments, executive transitions and the announcement of quarterly financial results.
Regulatory documents also detail Intel’s relationship with the U.S. government as a significant equity holder, the terms of warrants and common stock issued in connection with CHIPS Act funding, and associated risk factors. Filings describe restrictions on the use of funds, limitations on certain capacity expansions and collaborations, and potential impacts on existing shareholders.
In addition, this page can surface Forms 3, 4 and 5 that report transactions by Intel’s directors and officers, along with proxy materials that discuss governance and board composition. With real-time updates from EDGAR and AI-generated summaries, readers can quickly identify new INTC filings, understand their implications and trace how Intel’s disclosures evolve over time.
Intel Corporation entered a Purchase Agreement with the U.S. Department of Commerce (DOC) under which the company agreed to issue up to 433,323,000 shares of common stock: 274,583,000 shares to be issued on the Closing Date (based on $20.74 per share if all Released Funds are received) and 158,740,000 shares to be held in escrow and released as Secure Enclave Disbursements are received (priced at $20.00 per share). The DOC will also receive warrants exercisable for up to 240,516,150 shares at an exercise price of $20.00 per share; warrants vest and become exercisable only if Intel ceases to directly or indirectly own at least 51% of its foundry business, and expire five years after closing.
The Purchase Agreement contemplates a Closing Date of August 26, 2025 (or as soon as practicable thereafter). Securities will be non-transferable by the DOC until after the first anniversary of closing and subject to restrictions thereafter. The Company must file a resale registration statement with the SEC on or before September 5, 2025. The filing also adds risk factors describing timing and funding uncertainties, potential dilution to existing stockholders, governance and voting impacts from significant DOC ownership, possible adverse effects on non-U.S. business, and other consequences from government ownership.
Intel Corporation announced it entered into a Securities Purchase Agreement with SoftBank Group Corp. under which SoftBank agreed to buy 86,956,522 shares of Intel common stock for an aggregate cash purchase price of $2.0 billion, equal to $23.00 per share. The Shares will be issued in a private placement relying on Section 4(a)(2) of the Securities Act of 1933 as a transaction not involving a public offering. The Purchase Agreement contains customary representations, warranties and covenants, and closing is subject to customary conditions, including expiration or termination of applicable waiting periods and any required approvals under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The company furnished a press release dated August 18, 2025 as Exhibit 99.1 to the Current Report.
Intel and related parties amended their April 14, 2025 transaction agreement to sell a majority interest in the Altera business. Amendment No. 1, entered August 11, 2025, makes technical changes to the purchase price calculation that the company does not expect to materially affect net cash proceeds. The amendment also shifts the earliest allowable closing to no earlier than September 12, 2025 and extends the outside closing date to September 13, 2025, providing additional time to satisfy closing conditions. The filing reiterates standard forward-looking disclosures and lists potential risks that could prevent or delay completion.
Intel Corp filed a Form 13F reporting institutional holdings with a Form 13F Information Table total value of $255,517,497. The report lists 3 table entries and names two other included managers: Intel Capital Corporation and Middlefield Ventures, Inc.
The filing is signed by Patrick Bombach, Assistant Corporate Secretary, and the report indicates this is a 13F holdings report.